Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04123470
Title A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lokon Pharma AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Baylor St Luke's Medical Center Houston Texas 77030 United States Details
Uppsala University Hospital Uppsala 75185 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field